CUDC-907 mesylate - CAS 1401998-36-4

CUDC-907 mesylate is a small molecule inhibitor of histone deacetylase and PI3 kinase developed by Curis. It is investigated in clinical trials for the treatment of relapsed or refractory lymphomas, thyroid cancer, multiple myeloma, breast cancer and other malignancies.

Others, PI3K, Apoptosis, HDAC

PI3K/Akt/mTOR signaling, Chromatin/Epigenetic, Others, DNA Damage/DNA Repair, Apoptosis

1401958

C24H28N8O7S2

604.66

CS(O)(=O)=O.COc1ccc(cn1)-c1nc(N2CCOCC2)c2sc(CN(C)c3ncc(cn3)C(=O)NO)cc2n1

-20°C

Ice Packs

Small Compound